Opioid antagonists for smoking cessation (Q24202118)

5

object named as

Judith J Prochaska

0 references

author name string

Tim Lancaster

2

0 references

Lindsay F Stead

3

0 references

A Eden Evins

Cochrane Database of Systematic Reviews

4

0 references

language of work or name

English

0 references

publication date

2013

0 references

published in

0 references

volume

6

0 references

page(s)

CD003086

0 references

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038652

Nicotine replacement therapy for smoking cessation

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038652

Nicotine receptor partial agonists for smoking cessation

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038652

Interventions for preventing weight gain after smoking cessation

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038652

Antidepressants for smoking cessation

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038652

Opioid antagonists for smoking cessation

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038652

Clonidine for smoking cessation

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038652

Naltrexone reduction of long-term smoking cessation weight gain in women but not men: a randomized controlled trial.

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038652

Effects of naltrexone on smoking cessation outcomes and weight gain in nicotine-dependent men and women.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038652

Comparisons of high-dose and combination nicotine replacement therapy, varenicline, and bupropion for smoking cessation: a systematic review and multiple treatment meta-analysis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038652

Varenicline effects on craving, cue reactivity, and smoking reward

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038652

Effect of night smoking, sleep disturbance, and their co-occurrence on smoking outcomes

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038652

Exploring the impact of gender and reproductive status on outcomes in a randomized clinical trial of naltrexone augmentation of nicotine patch

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038652

Low-dose naltrexone augmentation of nicotine replacement for smoking cessation with reduced weight gain: a randomized trial

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038652

Comparing topiramate with naltrexone in the treatment of alcohol dependence

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038652

Dose-dependent reduction of hazardous alcohol use in a placebo-controlled trial of naltrexone for smoking cessation

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038652

Correspondence of Interactive Voice Response (IVR) reports of nicotine withdrawal, craving, and negative mood with questionnaire ratings

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038652

A preliminary investigation of naltrexone augmentation of bupropion to stop smoking with less weight gain

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038652

Factor structure and validity of the Medication Adherence Questionnaire (MAQ) with cigarette smokers trying to quit

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038652

Smoke and mirrors: magnified beliefs that cigarette smoking suppresses weight.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038652

Efficacy of naltrexone in smoking cessation: a preliminary study and an examination of sex differences

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038652

Do daily interactive voice response reports of smoking behavior correspond with retrospective reports?

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038652

Opioid antagonists for smoking cessation.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038652

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038652

Dopamine D2 receptor gene variants: association and linkage studies in impulsive-addictive-compulsive behaviour

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038652

Naloxone hydrochloride: a review

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038652

Naltrexone in the treatment of alcohol dependence

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038652

Naloxone does not affect cigarette smoking

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038652

Role of naltrexone in initial smoking cessation: preliminary findings

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038652

The effect of bupropion on nicotine craving and withdrawal

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038652

Effects of naltrexone with nicotine replacement on smoking cue reactivity: preliminary results.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038652

Effect of naloxone on cigarette smoking

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038652

Opiate antagonists reduce cocaine but not nicotine self-administration

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038652

Naltrexone blockade of nicotine effects in cigarette smokers

30 May 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003086.PUB3

Naltrexone alteration of acute smoking response in nicotine-dependent subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003086.PUB3

Naltrexone alteration of the nicotine-induced EEG and mood activation response in tobacco-deprived cigarette smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003086.PUB3

Naloxone challenge in smokers. Preliminary evidence of an opioid component in nicotine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003086.PUB3

Changes of smoking behavior and serum adrenocorticotropic hormone, cortisol, prolactin, and endogenous opioids levels in nicotine dependence after naltrexone treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003086.PUB3

An inpatient study of the effects of buprenorphine on cigarette smoking in men concurrently dependent on cocaine and opioids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003086.PUB3

Association of OPRM1 A118G variant with the relative reinforcing value of nicotine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003086.PUB3

Pharmacological effects of naltrexone and intravenous alcohol on craving for cigarettes among light smokers: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003086.PUB3

Naltrexone treatment for alcoholics: effect on cigarette smoking rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003086.PUB3

Naltrexone reduces the relative reinforcing value of nicotine in a cigarette smoking choice paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003086.PUB3

Naltrexone, smoking behaviour and cigarette withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003086.PUB3

Naltrexone administration affects ad libitum smoking behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003086.PUB3

Effects of topiramate or naltrexone on tobacco use among male alcohol-dependent outpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003086.PUB3

A controlled trial of naltrexone augmentation of nicotine replacement therapy for smoking cessation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003086.PUB3

The impact of depressive symptoms on the efficacy of naltrexone in smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003086.PUB3

A randomized trial of naltrexone for smoking cessation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003086.PUB3

Twenty-four week maintenance treatment of cigarette smoking with nicotine gum, clonidine and naltrexone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003086.PUB3

Naltrexone augments the effects of nicotine replacement therapy in female smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003086.PUB3

Naltrexone and nicotine patch smoking cessation: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003086.PUB3

Effects on smoking cessation: naltrexone combined with a cognitive behavioral treatment based on the community reinforcement approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003086.PUB3

An open-label study of naltrexone and bupropion combination therapy for smoking cessation in overweight and obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003086.PUB3

Met-enkephalin and preproenkephalin mRNA changes in the striatum of the nicotine abstinence mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003086.PUB3

Naloxone precipitates nicotine abstinence syndrome and attenuates nicotine-induced antinociception in mice.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038652

Naltrexone attenuates acute cigarette smoking behavior

29 November 2018

1 reference

12 December 2020

Failure of naloxone to modify the anti-tobacco effect of acupuncture (author's transl)

1 reference

12 December 2020

Naloxone reduces cigarette smoking

1 reference

12 December 2020

Bioequivalence, dose-proportionality, and pharmacokinetics of naltrexone after oral administration

1 reference

12 December 2020

Buprenorphine effects on cigarette smoking

1 reference

12 December 2020

Naloxone precipitates nicotine abstinence syndrome in the rat

1 reference

12 December 2020

Nicotine alleviation of nicotine abstinence syndrome is naloxone-reversible

1 reference

12 December 2020

Naltrexone effects on short-term and long-term smoking cessation

1 reference

12 December 2020

High-dose transdermal nicotine and naltrexone: effects on nicotine withdrawal, urges, smoking, and effects of smoking

1 reference

12 December 2020

10.1002/14651858.CD003086.PUB3

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

4474888

Fatcat ID

release_zozkl6n4xjbzbicw2yrun5kb74

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zozkl6n4xjbzbicw2yrun5kb74

24 November 2022

mapped directly with Wikidata item

OpenCitations bibliographic resource ID

4474888

1 reference